- Updated: Allen Institute launches $400M effort to turn brain atlas lessons into medicinesA Seattle-based nonprofit known for basic brain research is launching a $400 million initiative to translate its knowledge into drug development for neurodegenerative diseases, including Alzheimer'…Endpoints · 1mo ago↗ source
- The cost of a PRV is twice as high as it was three years ago — and it’s likely to stay that wayHow much is a regulatory shortcut worth? The cost of a priority review voucher, which shortens the FDA’s standard review time by about four months, has roughly doubled in the last few years. The…Endpoints · 1mo ago↗ source
- Epigenetic editing shows promise against chronic hep B infectionsA new method of CRISPR-based gene editing shows promise in curtailing chronic hepatitis B infections. Its twist is to silence disease-causing genes without altering the underlying DNA. Tune Thera…